After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, ESPR falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Esperion Therapeutics Inc is $906.05M. A total of 4.19 million shares were traded on the day, compared to an average of 7.05M shares.
In the most recent transaction, Looker Benjamin bought 1,248 shares of ESPR for 2.62 per share on Oct 17 ’25. In a previous transaction on Sep 17 ’25, Looker Benjamin sold 6,267 shares at 2.80 per share. ESPR shares that General Counsel owns now total 393,670.
Among the insiders who sold shares, Koenig Sheldon L. disposed of 28,427 shares on Sep 17 ’25 at a per-share price of $2.79. This resulted in the President and CEO holding 1,518,831 shares of ESPR after the transaction. In another insider transaction, Halladay Benjamin sold 7,046 shares at $2.81 per share on Sep 17 ’25. Company shares held by the Chief Financial Officer now total 474,862.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, ESPR has a high of $4.03 and a low of $0.69.
As of this writing, ESPR has an earnings estimate of $0.28 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of $0.53 per share and a lower estimate of -$0.03. The company reported an EPS of -$0.1 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. ESPR’s latest balance sheet shows that the firm has $259.33M in Cash & Short Term Investments as of fiscal 2021. There were $260.20M in debt and $73.35M in liabilities at the time. Its Book Value Per Share was -$2.20, while its Total Shareholder’s Equity was -$196.94M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ESPR is Buy with a score of 4.11.
